On ECHEMI
Home > Drugs > Tracheal tumors
Tracheal tumors
Tracheal tumors are divided into two categories: benign tumors and malignant tumors. The vast majority (90%) of tracheal tumors in children are benign, while the majority of adult tracheal tumors are malignant. Tracheal tumors are often misdiagnosed or missed due to their low incidence and doctors' low awareness and lack of knowledge of the disease, and few patients can receive timely and correct treatment. This disease should be treated surgically regardless of whether it is benign or malignant. After the benign tumor is removed, the patient will recover completely, and if the malignant tumor can be removed in time and thoroughly, a good therapeutic effect can also be achieved.
  • Site of disease:

    trachea
  • Infectious :

    Not contagious
  • Frequent population:

    No special disease group
  • Related symptoms:

    Lung mass Sputum has a foul smell Shoulder and back pain Cough Coughing up phlegm
  • Concurrent disease:

Related Drugs
Cough Relief Tangerine Pills
Manufacturer:

Tong Ren Tang Technologies Co., Ltd.

Taihe Miaoling Pills
Manufacturer:

Beijing Tongrentang Co., Ltd. Tongrentang Pharmaceutical Factory

Children's Qingfei cough tablets
Manufacturer:

Harbin Pharmaceutical Group Sanjing Children's Pharmacy (Co., Ltd.)

Formoterol Fumarate Tablets
Indication: It is used to treat breathing difficulties caused by airway obstructive diseases such as bronchial asthma, chronic tracheitis, asthmatic bronchitis, emphysema, etc. It is especially suitable for patients who need to take adrenaline β2 receptor agonists for a long time and patients with nocturnal asthma.
Manufacturer:

Tianjin Lisheng Pharmaceutical Co., Ltd.

Tankejingsan
Manufacturer:

Guangzhou WANG Laoji Pharmaceutical Company Limited

Tiotropium Bromide Powder for Inhalation
Indication: This product is a bronchodilator, suitable for the maintenance treatment of chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphysema, the maintenance treatment of dyspnea and the prevention of acute attacks.
Related Ingredients
Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.